SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000886163-24-000056
Filing Date
2024-07-09
Accepted
2024-07-09 16:52:19
Documents
6
Effectiveness Date
2024-07-09

Document Format Files

Seq Description Document Type Size
1 S-8 ligand-formsx8_july2024.htm S-8 114021
2 EX-FILING FEES exhibit107_july2024.htm EX-FILING FEES 20433
3 EX-5.1 ligand-51opiniontosx8final.htm EX-5.1 17972
4 EX-23.1 s-8_exhibit231x792024.htm EX-23.1 2368
5 contact.jpg GRAPHIC 16766
6 logo.jpg GRAPHIC 7087
  Complete submission text file 0000886163-24-000056.txt   188940
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280733 | Film No.: 241107927
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)